EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
54 hedge funds and large institutions have $61M invested in ESSA Pharma in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
-5
Holders Change %
-8.47%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
15
Closed
15
Calls
$80K
Puts
–
Net Calls
+$80K
Net Calls Change
+$24K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$9.19M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$1.62M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$940K |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$696K |
| 5 |
Two Sigma Investments
New York
|
+$539K |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$9.17M |
| 2 |
Blackstone Inc
New York
|
-$6.31M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$3.28M |
| 4 |
Morgan Stanley
New York
|
-$2.85M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$2.78M |
